Friday, July 10, 2026

pharma · Refractory Partial Onset Epilepsy · Multiple Sclerosis

NEURAXPHARM AUSTRALIA PTY

News and analysis for NEURAXPHARM AUSTRALIA PTY on NovaPharmaNews — regulatory, clinical, and market coverage.

Melbourne, AU HQ
11 Employees
TGA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Employees
11
Programs
3
Drugs
17
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning NEURAXPHARM AUSTRALIA PTY — regulatory, clinical, and market coverage.

News and analysis for NEURAXPHARM AUSTRALIA PTY on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning NEURAXPHARM AUSTRALIA PTY yet.

Back to company overview →